Diarrhoeagenic Escherichia coli associated with childhood diarrhoea in Osun state, Nigeria.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
08 Sep 2024
Historique:
received: 25 04 2024
accepted: 22 08 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 8 9 2024
Statut: epublish

Résumé

Diarrhoea is a major public health concern in developing countries, usually exacerbated by poor water, sanitation and hygiene but its aetiology is under-studied, particularly away from capital cities. We identified diarrhoeagenic Escherichia coli (DEC) from stools collected in Ile-Ife and Ilesa, Osun state, Nigeria and determined their antibiotic resistance profiles. Stool samples from 167 children with diarrhoea and 334 controls under the age of 5 years were cultured for Escherichia coli and Salmonella. Bacterial isolates were identified biochemically and DEC were identified by PCR. Antimicrobial susceptibility testing was by modified Kirby-Bauer disc diffusion method in accordance with the CLSI guidelines. Data were analyzed using Chi-square and Fisher's exact tests. Diarrhoea infection is significantly high among children under 12 months (p = 0.002), caregivers without at least primary school education (p = 0.006), breastfeeding for under 6 months (p˂0.001), and caregivers who were siblings (p = 0.004). DEC was detected in 69(41.3%) cases but only 86(25.7%) controls (p < 0.001) and more commonly recovered during the wet season (p < 0.001). Enterotoxigenic E. coli (p = 0.031), enteropathogenic E. coli (p = 0.031) and Shiga-toxin-producing E. coli (p = 0.044) were recovered more commonly from cases than controls. DEC from patients with diarrhoea were commonly resistant to sulphonamides (91.3%), trimethoprim (82.6%), and ampicillin (78.3%) but were largely susceptible to quinolones and carbapenems (97.1%). Enteropathogenic, enterotoxigenic and Shiga toxin-producing E. coli are associated with diarrhoea in our setting, and show considerable resistance to first-line antimicrobials. Risk factors for DEC diarrhoea include infancy, inadequate breastfeeding and caregivers with education below primary school.

Identifiants

pubmed: 39245731
doi: 10.1186/s12879-024-09793-0
pii: 10.1186/s12879-024-09793-0
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

928

Subventions

Organisme : African Research Leader's Award
ID : MR/L00464X/1
Organisme : Bill & Melinda Gates Foundation
ID : INV-036234
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

World Health Organization. (2023). Diarrhoeal disease. Retrieved January 21, 2023, from https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease
Mokomane M, Kasvosve I, de Melo E, Pernica JM, Goldfarb DM. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. Therapeutic Adv Infect Disease. 2018;5(1):29–43.
doi: 10.1177/2049936117744429
UNICEF. (2020). Under five mortality. http://data.unicef.org/topic/child-survival/under-five-mortality/
Ugboko HU, Nwinyi OC, Oranusi SU, Fagbeminiyi FF. (2021). Risk factors of diarrhoea among children under five years in Southwest Nigeria. Int J Microbiol pp. 1–9.
Kotloff KL, Nasrin D, Blackwelder WC, Wu Y, Farag T, Panchalingham S, Sow SO, Sur D, Zaidi AKM, Faruque ASG, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Levine MM. The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the global enteric Multicenter Study (GEMS). Lancet Global Health. 2019;7(5):e568–84.
pubmed: 31000128 doi: 10.1016/S2214-109X(19)30076-2
Onanuga A, Igbeneghu O, Lamikanra A. A study of the prevalence of diarrhoeagenic Escherichia coli in children from Gwagwalada, Federal Capital, Nigeria. Pan Afr Med J. 2014;17:146.
pubmed: 25379115 pmcid: 4219803 doi: 10.11604/pamj.2014.17.146.3369
Okeke IN, Lamikanra A, Steinruck H, Kaper JB. Characterization of Escherichia coli strains from cases of childhood diarrhoea in provincial southwestern Nigeria. J Clin Microbiol. 2000;38:7–12.
pubmed: 10618054 pmcid: 86005 doi: 10.1128/JCM.38.1.7-12.2000
Opintan JA, Newman MJ, Arhin RE, Donkor ES. Laboratory- based nationwide surveillance of antimicrobial resistance in Ghana. Infect Drug Resist. 2015;54:191.
Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods of sampling and estimation of sample size. In: Kelsey JL, Whittemore AS, Evans AS, Thompson WD, editors. Methods in Observational Epidemiology. New York: Oxford University Press; 1996.
Okeke I, Ojo O, Lamikanra A, Kaper J. Etiology of acute diarrhoea in adults in southwestern, Nigeria. J Clin Microbiol. 2003;41:4525–30.
pubmed: 14532177 pmcid: 254369 doi: 10.1128/JCM.41.10.4525-4530.2003
Clinical and Laboratory Standards Institute (CLSI). (2024). Supplement M100: Performance Standards for Antimicrobial Susceptibility Testing. (L. L. Kristy and M. Laura, editors; 34th ed.).
Promega Corporation. Wizard genomic DNA purification kit Technical Manual. Madison, WI: Promega Corporation; 2019.
Aranda K, Fagundes-Neto U, Scaletsky I. Evaluation of multiplex PCRs for diagnosis of infection with diarrhoeagenic Escherichia coli and Shigella spp. J Clin Microbiol. 2004;42:5849–53.
pubmed: 15583323 pmcid: 535216 doi: 10.1128/JCM.42.12.5849-5853.2004
Odetoyin BW, Hofmann J, Aboderin AO, Okeke IN. Diarrhoeagenic Escherichia coli in mother-child pairs in Ile-Ife, South Western Nigeria. BMC Infect Disease. 2015;16:28.
doi: 10.1186/s12879-016-1365-x
Rolande M, Mabika RM, Liabagui SL, Moundounga HK, Mounioko F, Souza A, Yala JF. Molecular prevalence and Epidemiological Characteristics of Diarrhoeagenic E. Coli in Children under 5 Years Old in the City of Koula-Moutou, East-Central Gabon. Open J Med Microbiol. 2021;11:157–75.
doi: 10.4236/ojmm.2021.113013
Ugboko HU, Nwinyi OC, Oranusi SU, Oyewale JO. (2020). Childhood diarrhoeal diseases in developing countries. Heliyon. 13;6(4):e03690.
Acosta GJ, Vigo NI, Durand D, Riveros M, Arango S, Zambruni M, Ochoa TJ. Diarrhoeagenic Escherichia coli: prevalence and pathotype distribution in children from Peruvian Rural communities. Am J Trop Med Hyg. 2016;95(3):574–9.
pubmed: 27382080 pmcid: 5014262 doi: 10.4269/ajtmh.16-0220
Ifeanyi CI, Ikeneche NF, Bassey BE, Al-Gallas N, Ben-Aissa R, Boudabous A. Diarrheagenic Escherichia coli pathotypes isolated from children with diarrhea in the Federal Capital Territory Abuja. Nigeria. J Infect Developing Ctries. 2015;19(2):165–74.
doi: 10.3855/jidc.5528
Addy PAK, Antepim G, Frimpong EH. Prevalence of pathogenic Escherichia coli and parasites in infants with diarrhoea in Kumasi, Ghana. East Afr Med J. 2004;81(7):353–7.
pubmed: 15490707 doi: 10.4314/eamj.v81i7.9190
Saka HK, Dabo NT, Muhammad B, García-Soto S, Ugarte-Ruiz M, Alvarez J. Diarrheagenic Escherichia coli Pathotypes from children younger than 5 years in Kano State, Nigeria. Front Public Health. 2019;7:348.
pubmed: 31828054 pmcid: 6890574 doi: 10.3389/fpubh.2019.00348
Rappelli P, Folgosa E, Solinas ML. Pathogenic enteric Escherichia coli in children with and without diarrhoea in Maputo, Mozambique. FEMS Immunol Med Microbiol. 2005;43(1):67–72.
pubmed: 15607638 doi: 10.1016/j.femsim.2004.07.006
Kaper JB, Nataro JP, Mobley HL. (2004). Pathogenic Escherichia coli. Nature Reviews Microbiology. (2004) 2:123–40. 10.1038
Haghi F, Zeighami H, Hajiahmadi F, Khoshvaght H, Bayat M. Frequency and antimicrobial resistance of diarrhoeagenic Escherichia coli from young children in Iran. J Med Microbiol. 2014;63:427–32.
pubmed: 24281909 doi: 10.1099/jmm.0.064600-0
Vilchez S, Reyes D, Paniagua M, Bucardo F, Möllby R, Weintraub A. Prevalence of diarrhoeagenic Escherichia coli in children from León, Nicaragua. J Med Microbiol. 2009;58:630–7.
pubmed: 19369525 doi: 10.1099/jmm.0.007369-0
Prah I, Ayibieke A, Nguyen TTH, Iguchi A, Mahazu S, Sato W, Hayashi T, Yamaoka S, Suzuki T, Iwanaga S, Ablordey A, Saito R. Virulence profiles of Diarrheagenic Escherichia coli isolated from the Western Region of Ghana. Jpn J Infect Dis. 2020;24(2):115–21.
doi: 10.7883/yoken.JJID.2020.356
Levine MM, Kotloff KL, Nataro JP, Muhsen K. The global enteric Multicenter Study (GEMS): impetus, rationale, and genesis. Clin Infect Disease. 2012;55(Suppl 4):S215–24.
doi: 10.1093/cid/cis761
Okoh AI, Osode AN. Enterotoxigenic Escherichia coli (ETEC): a recurring decimal in infants’ and travelers’ diarrhoea. Rev Environ Health. 2008;23:135–48.
pubmed: 18763541 doi: 10.1515/REVEH.2008.23.2.135
Qadri F, Ahmed A, Tarique A, Begum T, A. and, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immunol. 2007;75(8):3961–8.
doi: 10.1128/IAI.00459-07
Moyo SJ, Maselle SY, Matee MI, Langeland N, Mylvaganam H. Identification of diarrhoeagenic Escherichia coli isolated from infants and children in Dares Salaam, Tanzania. BioMed Cent Infect Disease. 2007;7:92.
doi: 10.1186/1471-2334-7-92
Khairy RMM, Fathy ZA, Mahrous DM, Mohamed ES, Abdelrahim SS. Prevalence, phylogeny, and antimicrobial resistance of Escherichia coli pathotypes isolated from children less than 5 years old with community acquired- diarrhoea in Upper Egypt. BMC Infect Dis. 2020;1:20(1):908.
pubmed: 33256619 doi: 10.1186/s12879-020-05664-6
Zhou Y, Zhu X, Hou H, Lu Y, Yu J, Mao L, Mao L, Sun Z. Characteristics of diarrhoeagenic Escherichia coli among children under 5 years of age with acute diarrhoea: a hospital-based study. BMC Infect Dis. 2018;1:18(1):63.
doi: 10.1186/s12879-017-2936-1
Bonkoungou IJO, Lienemann T, Martikainen O, Dembele R, Sanou I, Traore AS, Siitonen A, Barro N, Haukka K. Diarrhoeagenic Escherichia coli detected by 16-plex PCR in children with and without diarrhoea in Burkina Faso. Clin Microbiol Infect. 2012;18:9.
doi: 10.1111/j.1469-0691.2011.03675.x
Okeke IN. Diarrhoeagenic Escherichia coli in sub-saharan Africa: status, uncertainties and necessities. J Infect Developing Ctries. 2009;3(11):817–42.
doi: 10.3855/jidc.586
Agho KE, Ezeh OK, Ghimire PR, Uchechukwu OL, Stevens GJ, Tannous WK, Fleming C, Ogbo FA. Global Maternal and Child Health Research collaboration (GloMACH). Exclusive Breastfeeding Rates and Associated Factors in 13 Economic Community of West African States (ECOWAS) Countries. Nutrients. 2019;11(12):3007.
pubmed: 31818035 pmcid: 6950341 doi: 10.3390/nu11123007
Acosta GJ, Vigo NI, Durand D, Riveros M, Arango S, Zambruni M, Ochoa TJ. Diarrhoeagenic Escherichia coli: prevalence and pathotype distribution in children from Peruvian Rural communities. Am J Trop Med Hyg. 2016;7(3):574–9.
doi: 10.4269/ajtmh.16-0220
Egbontan AE, Ojo OA, Jacob SJ. Prevalence of Diarrhoea causing microorganisms among children that are exclusively breastfed and those on Weaning Foods. Pac J Sci Technol. 2013;14(1):334–41.
Ali M, Ahmed I, Yusha’u M, Shehu AA. (2023). Prevalence of Diarrhoea and Risk Associated factors among children under 5 years in Kano, North-western Nigeria. Archives Pharm Pharmacol Res. 3(3).
Akinlabi OC, Nwoko EQ, Dada RA, Ekpo S, Omotuyi A, Nwimo CC, et al. Epidemiology and risk factors for diarrheagenic escherichia coli carriage among children in Northern Ibadan, Nigeria. Am J Trop Med Hyg. 2023;109(6):1223–32.
Duche RT, Amali O, Umeh EU. Bacterial contamination of children’s Weaning foods in Asase, North Bank, Makurdi. Int J Sci Eng Res. 2013;4(8):2184–225.
Das R, Palit P, Haque MA, Ahmed T, Faruque ASG. Association between Pathogenic Variants of Diarrhoeagenic Escherichia coli and Growth in Children under 5 years of age in the global enteric Multicenter Study. Am J Trop Med Hyg. 2022;6(1071):72–81.
doi: 10.4269/ajtmh.22-0096
GebreSilasie YM, Tullu KD, Yeshanew AG. Resistance pattern and maternal knowledge, attitude and practices of suspected Diarrhoeagenic Escherichia coli among children under 5 years of age in Addis Ababa, Ethiopia: cross sectional study. Antimicrob Resist Infect Control. 2018;7:110.
pubmed: 30214719 pmcid: 6134717 doi: 10.1186/s13756-018-0402-5
Mattioli MC, Boehm AB, Davis J, Harris AR, Mrisho M. Enteric Pathogens in Stored Drinking Water and on Caregiver’s hands in Tanzanian households with and without reported cases of child diarrhoea. PLoS ONE. 2014;9(1):e84939.
pubmed: 24392161 pmcid: 3879350 doi: 10.1371/journal.pone.0084939
Tumwine JK, Thompson J, Katua-Katua M, Mujwajuzi M, Johnstone N, Porras I. Diarrhoea and effects of different water sources, sanitation and hygiene behaviour in East Africa. Trop Med Int Health. 2002;7(9):750–6.
pubmed: 12225505 doi: 10.1046/j.1365-3156.2002.00927.x
El Metwally HAR, Ibrahim HAH, El-Athamna MN, Amer MA. Multiplex PCR for detection of Diarrheagenic Escherichia coli in Egyptian Children. J Med Sci. 2007;7(2):255–62.
doi: 10.3923/jms.2007.255.262
WHO (World Health Organisation). (2020). Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. In World Health Organization (pp. 1–7).
Bruzzese E, Giannattasio A, Guarino A. Antibiotic treatment of acute gastroenteritis in children. F1000Research. 2018;15:7.
Von Baum H, Marre R. Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol. 2005;295:503–11.
doi: 10.1016/j.ijmm.2005.07.002
Cavany S, Nanyonga S, Hauk C. The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance. Nat Commun. 2023;14:6153.
pubmed: 37788991 pmcid: 10547756 doi: 10.1038/s41467-023-41542-w
Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–87.
pubmed: 26603922 doi: 10.1016/S0140-6736(15)00473-0
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.
doi: 10.1016/S0140-6736(21)02724-0
Akinlabi OC, Dada RA, Nwoko EQA, Okeke IN. PCR diagnostics are insufficient for the detection of Diarrhoeagenic Escherichia coli in Ibadan, Nigeria. PLOS Global Public Health. 2023;7(8):e0001539.
doi: 10.1371/journal.pgph.0001539

Auteurs

Ademola A Olayinka (AA)

Department of Medical Microbiology and Parasitology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun, Nigeria. olayinkaademolaa@gmail.com.

Ibukunoluwa O Oginni-Falajiki (IO)

Department of Medical Microbiology and Parasitology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun, Nigeria.

Iruka N Okeke (IN)

Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.

Aaron O Aboderin (AO)

Department of Medical Microbiology and Parasitology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun, Nigeria.
Department of Medical Microbiology and Parasitology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH